Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

Anesthesiology

Volumn 100, Issue 6, 2004, Pages 1582-1594

  Follett, Kenneth A ^a   Boortz Marx, Richard L ^b   Drake, James M ^c   DuPen, Stuart ^d,e   Schneider, Steven J ^f,g   Turner, Michael S ^h   Coffey, Robert J ⁱ  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

^e SWEDISH MEDICAL CENTER   (United States)

^f NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^g LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^h Indianapolis Neurosurgical Group   (United States)

ⁱ MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL HEART PACEMAKER; CANCER PAIN; CEREBROSPINAL FLUID FISTULA; CEREBROSPINAL FLUID SHUNTING; DEVICE INFECTION; DEVICE REMOVAL; DRUG DELIVERY SYSTEM; HUMAN; INFECTION PREVENTION; INTRACTABLE PAIN; OPERATING ROOM; PATIENT SELECTION; POSTMARKETING SURVEILLANCE; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PSEUDOMONAS; REIMPLANTATION; REVIEW; SEIZURE; SPASTICITY; SPINAL CORD STIMULATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; SYSTEMATIC REVIEW; URINARY TRACT INFECTION;

EQUIPMENT CONTAMINATION; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; NEUROSURGICAL PROCEDURES; SPINAL CORD; SURGICAL WOUND INFECTION;

EID: 2542444294     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200406000-00034     Document Type: Review

References (65)

1. Follett KA, Naumann KP: A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 2000; 19: 209-15
2. Spincemaille GH, Klomp HM, Steyerberg EW, van Urk H, Habbema JD, ESES Study Group: Technical data and complications of spinal cord stimulation: Data from a randomized trial on critical limb ischemia. Stereotact Funct Neurosurg 2000; 74:63-72
3. Albright AL: Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996; 11(suppl 1):S29-35
4. Coffey RJ, Cahill D, Steers W, Park TS, Meythaler J, Herman R, Shetter AG, Levy R, Gill B, Smith R, Wilberger J, Loeser JD, Chabal C, Feler C, Robertson JT, Penn RD, Clarke A, Burchiel K, Leibrock LG: Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study. J Neurosurg 1993; 78:226-32
5. Stempien L, Tsai T: Intrathecal baclofen pump use for spasticity: A clinical survey. Am J Phys Med Rehabil 2000; 79:536-41
6. Follett KA, Burchiel K, Deer T, DuPen S, Prager J, Turner MS, Coffey RJ: Prevention of intrathecal drug delivery catheter-related complications. Neuromodulation 2003; 6:32-41
7. Hassenbusch S, Burchiel K, Coffey RJ, Cousins MJ, Deer T, Hahn MB, Du Pen S, Follett KA, Krames E, Rogers JN, Sagher O, Staats PS, Wallace M, Willis KD: Management of intrathecal catheter-tip inflammatory masses: A consensus statement. Pain Med 2002; 3:1-12
8. Coffey RJ, Edgar TS, Francisco GE, Graziana V, Meythaler JM, Ridgely PM, Sadiq SA, Turner MS: Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 2002; 83:735-41
9. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR: Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999; 20: 247-78
10. Nichols RL: Preventing surgical site infections: A surgeon's perspective. Emerg Infect Dis 2001; 7:220-4
11. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE: Risk of infection after cerebrospinal fluid shunt: An analysis of 884 first-time shunts. Acta Neurochirurgica (Wien) 1995; 136:1-7
12. Choux M, Genitori L, Lang D, Lena G: Shunt implantation: Reducing the incidence of shunt infection. J Neurosurg 1992; 77:875-80
13. Dallacasa P, Dappozzo A, Galassi E, Sandri F, Cocchi G, Masi M: Cerebrospinal fluid shunt infections in infants. Childs Nerv Syst 1995; 11:643-8
14. Davis SE, Levy ML, McComb JG, Masri-Lavine L: Does age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatr Neurosurg 1999; 30:253-7
15. Di Rocco C, Marchese E, Velardi F: A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus: Cooperative survey of the 1991-1992 Education Committee of the ISPN. Childs Nerv Syst 1994; 10:321-7
16. Drake JM, Kestle JR, Tuli S: CSF shunts 50 years on: Past, present and future. Childs Nerv Syst 2000; 16:800-4
17. Ersahin Y, Ersahin Y, Mutluer S, Guzelbag E: Cerebrospinal fluid shunt infections: Cerebrospinal fluid shunt infections. J Neurosurg Sci 1994; 38:161-5
18. Fan-Havard P, Nahata MC: Treatment and prevention of infections of cerebrospinal fluid shunts. Clinical Pharmacology. 1987; 6:866-80
19. Filka J, Huttova M, Tuharsky J, Sagat T, Kralinsky K, Krcmery V Jr: Nosocomial meningitis in children after ventriculoperitoneal shunt insertion. Acta Paediatr 1999; 88:576-8
20. Griebel R, Khan M, Tan L: CSF shunt complications: An analysis of contributory factors. Childs Nerv Syst 1985; 1:77-80
21. Haines SJ, Walters BC: Antibiotic prophylaxis for cerebrospinal fluid shunts: A metanalysis. Neurosurgery 1994; 34:87-92
22. Horgan MA, Piatt JH Jr: Shaving of the scalp may increase the rate of infection in CSF shunt surgery. Pediatr Neurosurg 1997; 26:180-4
23. Kestle JR, Hoffman HJ, Soloniuk D, Humphreys RP, Drake JM, Hendrick EB: A concerted effort to prevent shunt infection. Childs Nerv Syst 1993; 9:163-5
24. Kontny U, Hofling B, Gutjahr P, Voth D, Schwarz M, Schmitt HJ: CSF shunt infections in children. Infection 1993; 21:89-92
25. Krcmery V, Paradisi F: Nosocomial bacterial and fungal meningitis in children: An eight year national survey reporting 101 cases. Pediatric Nosocomial Meningitis Study Group. Int J Antimicrob Agents 2000; 15:143-7
26. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: A prospective study of risk factors. J Neurosurg 2001; 94:195-201
27. Lambert M, MacKinnon AE, Vaishnav A: Comparison of two methods of prophylaxis against CSF shunt infection. Zeitschrift fur Kinderchirurgerie 1984; 29(suppl 2):109-10
28. Langley JM, LeBlanc JC, Drake J, Milner R: Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: Meta-analysis. Clin Infect Dis 1993; 17:98-103
29. McCullough DC, Kane JG, Presper JH, Wells M: Antibiotic prophylaxis in ventricular shunt surgery: I. Reduction of operative infection rates with methicillin. Childs Brain 1980; 7:182-9
30. Piatt JH Jr, Carlson CV: A search for determinants of cerebrospinal fluid shunt survival: Retrospective analysis of a 14-year institutional experience Pediatr Neurosurg 1993; 19:233-41
31. Pople IK, Bayston R, Hayward RD: Infection of cerebrospinal fluid shunts in infants: A study of etiological factors. J Neurosurg 1992; 77:29-36
32. Quie PG, Belani KK: Coagulase-negative staphylococcal adherence and persistence. J Infect Dis 1987; 156:543-7
33. Renier D, Lacombe J, Pierre-Kahn A, Sainte-Rose C, Hirsch J-F: Factors causing acute shunt infection: Computer analysis of 1174 operations. J Neurosurg 1984; 61:1072-8
34. Steinbok P, Cochrane DD, Kestle RW: The significance of bacteriologically positive ventriculoperitoneal shunt components in the absence of other signs of shunt infection. J Neurosurg 1996; 84:617-23
35. Stromblad LG, Schalén C, Steen A, Sundbärg G, Kamme C: Bacterial contamination in cerebrospinal fluid shunt surgery. Scand J Infect Dis 1987; 19:211-4
36. Tuli S, Drake J, Lawless J, Wigg M, Lamberti-Pasculli M: Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg 2000; 92:31-8
37. Walters BC, Goumnerova L, Hoffman HJ, Hendrick EB, Humphreys RP, Levinton C: A randomized controlled trial of perioperative rifampin/ trimethoprim in cerebrospinal fluid shunt surgery. Childs Nerv Syst 1992; 8:253-7
38. Wang KC, Lee HJ, Sung JN, Cho BK: Cerebrospinal fluid shunt infection in children: Efficiency of management protocol, rate of persistent shunt colonization, and significance of 'off-antibiotics' trial. Childs Nerv Syst 1999; 15:38-43
39. Younger JJ, James CH, Simmons MD, Barrett FF: Operative related infection rates for ventriculoperitoneal shunt procedures in a children's hospital. Infect Control 1987; 8:67-70
40. Zemack G, Romner B: Seven years of clinical experience with the programmable Codman Hakim valve: A retrospective study of 583 patients. J Neurosurg 2000; 92:941-8
41. Zentner J, Gilsbach J, Felder T: Antibiotic prophylaxis in cerebrospinal fluid shunting: A prospective randomized trial in 129 patients. Neurosurg Rev 1995; 18:169-72
42. Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, Piatt J, Haines S, Schiff S, Cochrane D, Steinbok P, MacNeil N: Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000; 33:230-6
43. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon S: Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133:604-8
44. Lai KK, Fontecchio SA: Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: Epidemiology, infection control, and management. Clin Infect Dis 1998; 27:265-9
45. Steckelberg JM, Wilson WR: Infections associated with implantable cardioverter defibrillators: Still more questions (editorial response). Clin Infect Dis 1998; 27:270-1
46. Smith PN, Vidaillet HJ, Hayes JJ, Wethington PJ, Stahl L, Hull M, Broste SK: Infections with nonthoracotomy implantable cardioverter defibrillators: Can these be prevented? Pacing Clin Electrophysiol 1998; 21(pt I):42-55
47. Trappe H-J, Pfitzner P, Klein H, Wenzlaff P: Infections after cardioverter-defibrillator implantation: Observations in 335 patients over 10 years. Br Heart J 1995; 73:20-4
48. Spratt KA, Blumberg EA, Wood CA, Kutalek SP, Reboli AC: Infections of implantable cardioverter defibrillators: Approach to management. Clin Infect Dis 1993; 17:679-85
49. Hartstein AL, Jackson J, Gilbert DN: Prophylactic antibiotics and the insertion of permanent transvenous cardiac pacemakers. J Thorac Cardiovasc Surg 1978; 75:219-23
50. Bluhm G, Nordlander R, Ransjo U: Antibiotic prophylaxis in pacemaker surgery: A prospective double-blind trial with systemic administration of antibiotic versus placebo at implantation of cardiac pacemakers. Pacing Clin Electrophysiol 1986; 9:720-6
51. Molina J: Undertreatment and overtreatment of patients with infected anti-arrhythmic implantable devices, Ann Thorac Surg 1997; 64:1702-6
52. Huebner J, Goldmann DA: Coagulase-negative staphylococci: Role as pathogens. Annu Rev Med 1999; 50:223-36
53. Farr BM: Mupirocin to prevent S. aureus infections. N Engl J Med 2002; 346:1905-6
54. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt, LA, and the Mupirocin and the Risk of Staphylococcus aureus Study Team: Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346:1871-7
55. Blomstedt B, Osrterberg B, Bergstrand A: Suture material and bacterial transport. Acta Chir Scand 1977; 143:71-3
56. Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL: Subfascial implantation of intrathecal baclofen pumps in children: Technical note. Neurosurgery 2001; 49:753-6
57. Bennett MI, Tai YM, Symonds JM: Staphylococcal meningitis following Synchromed intrathecal pump implant: A case report. Pain 1994; 56:243-4
58. Galloway A, Falope FZ: Pseudomonas aeruginosa infection in an intrathecal baclofen pump: Successful treatment with adjunct intra-reservoir gentamicin. Spinal Cord 2000; 38:126-8
59. Samuel M, Finnerty GT, Rudge P: Intrathecal baclofen pump infection treated by adjunct intrareservoir antibiotic instillation. J Neurol Neurosurg Psychiatry 1994; 57:1146-7
60. Zed PJ, Stiver HG, Devonshire V, Jewesson PJ, Marra F: Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitis: Case report. J Neurosurg 2000; 92:347-9
61. Penn RD: Intrathecal baclofen for spasticity of spinal origin: Seven years of experience. J Neurosurg 1992; 77:236-40
62. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003; 9:589-95
63. Bayston R, Lambert E: Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 1997; 87:247-51
64. Hampl J, Schierholz J, Jansen B, Aschoff A: In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochirurgica (Wien) 1995; 133:147-52
65. Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, Kunze S, Aschoff A: Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 2000; 49:441-50